Heart Failure During Cardiac Pacing
Open Access
- 2 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 113 (17) , 2082-2088
Abstract
Background— Right ventricular apical (RVA) pacing creates abnormal left ventricular contraction, hypertrophy, and reduced pump function. The adverse effects of ventricular desynchronization may explain the association of RVA pacing with an increased risk of heart failure hospitalization (HFH) in clinical trials. Methods and Results— Baseline and postimplantation variables were used to predict HFH in the Mode Selection Trial, a 2010-patient, 6-year trial of dual-chamber (DDDR) versus ventricular (VVIR) pacing in sinus node dysfunction. A Cox model showed that New York Heart Association (NYHA) class at baseline and follow-up predicted HFH (hazard ratio [HR], 3.99; 95% confidence interval [CI], 2.74–5.79 for NYHA class III/IV and HR, 2.17; 95% CI, 1.54–3.04 for NYHA class II versus class I); other predictors were heart failure (HR, 2.30; 95% CI, 1.70–3.11), atrioventricular (AV) block (HR, 1.48; 95% CI, 1.11–1.97), and myocardial infarction (MI)(HR, 1.37; 95% CI, 1.00–1.86). Postimplantation predictors were VVIR cumulative percent ventricular pacing (Cum%VP) >80 (HR, 3.58; 95% CI, 1.72–7.45), DDDR Cum%VP >40 or VVIR Cum%VP ≤80 (HR, 1.81; 95% CI, 0.94–3.50) versus DDDR Cum%VP ≤40; whether QRS duration (QRSd) was paced or spontaneous (HR, 2.21; 95% CI, 1.39–3.54; spontaneous versus paced); and drugs for atrial fibrillation (HR, 1.60; 95% CI, 1.19–2.15). Low baseline ejection fraction (EF) and postimplantation RVA-paced or spontaneous QRSd predicted HFH; the increased risk with QRSd was steeper for normal versus low EF (HR, 1.18; 95% CI, 1.11–1.27; versus HR, 1.08; 95% CI, 1.01–1.15; for a 10-ms increase); at a QRSd of ≈200 ms, normal- and low-EF patients had equivalent risk. HFH risk nearly doubled when VVIR Cum%VP was ≤80 or DDDR Cum%VP was >40 versus DDDR Cum%VP ≤40 and was additive with other risk factors. Conclusions— Differences in HFH risk can be explained by interactions between substrate (atrial fibrillation, AV conduction, heart failure, MI, EF) and pacing promoters (ventricular desynchronization-paced QRSd and Cum%VP, and AV desynchronization-pacing mode). Management of RVA pacing is important for reducing the risk of HFH, particularly among patients with low EF and heart failure.Keywords
This publication has 23 references indexed in Scilit:
- The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial IIJournal of Cardiovascular Electrophysiology, 2005
- Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS durationHeart Rhythm, 2005
- Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical PacingCirculation, 2004
- Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node DysfunctionJournal of Cardiovascular Electrophysiology, 2004
- A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndromeJACC, 2003
- Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node DysfunctionCirculation, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patientsAmerican Heart Journal, 2000
- Left ventricular endocardial activation during right ventricular pacing: Effect of underlying heart diseaseJACC, 1986
- Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: relation to altered regional left ventricular functionJACC, 1984